熱門資訊> 正文
诺维信A/S报告第一季度业绩
2026-05-05 22:16
- Novozymes A/S press release (NVZMF): Q1 Sales amounted to EUR 1.12B, 7% organic sales growth Y/Y.
- Adjusted earnings per share was EUR 0.44.
- 2026 outlook confirmed: Organic sales growth is expected to be in the range of 5-7%.
More on Novozymes A/S
- Novozymes A/S (NVZMY) Q1 2026 Earnings Call Transcript
- Novozymes A/S 2026 Q1 - Results - Earnings Call Presentation
- Novozymes A/S (NVZMY) Shareholder/Analyst Call - Slideshow
- Top and bottom quant-rated materials stocks over $10B: Coeur Mining leads 'Strong Buys'
- Seeking Alpha’s Quant Rating on Novozymes A/S
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。